468068-28-2 Usage
Description
6-Amino-N-hydroxy-3-pyridinecarboximidamide is a chemical compound with the molecular formula C6H8N4O. It is a derivative of pyridine and contains an amino group and a hydroxy group. 6-Amino-N-hydroxy-3-pyridinecarboximidamide is not commonly recognized in scientific literature, and its specific properties and uses are not well-documented.
Uses
Used in Organic Synthesis:
6-Amino-N-hydroxy-3-pyridinecarboximidamide is used as a building block in organic synthesis for the creation of various complex organic molecules. Its functional groups, including the amino and hydroxy groups, allow it to participate in a range of chemical reactions, making it a versatile component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Medicinal Chemistry:
Due to its potential to interact with biological systems, 6-Amino-N-hydroxy-3-pyridinecarboximidamide is used as a starting material or intermediate in medicinal chemistry. Its functional groups may enable it to form complexes with enzymes, receptors, or other biomolecules, which could lead to the development of new drugs or drug candidates with therapeutic potential.
Further research and testing would be needed to fully understand the potential uses and properties of 6-Amino-N-hydroxy-3-pyridinecarboximidamide, as its specific applications and characteristics are not well-documented in the scientific literature.
Check Digit Verification of cas no
The CAS Registry Mumber 468068-28-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,8,0,6 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 468068-28:
(8*4)+(7*6)+(6*8)+(5*0)+(4*6)+(3*8)+(2*2)+(1*8)=182
182 % 10 = 2
So 468068-28-2 is a valid CAS Registry Number.
468068-28-2Relevant articles and documents
PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGIUR2 ANTAGONISTS
-
Page/Page column 43, (2010/11/29)
The present invention relates to compounds of formula (I), a process for the manufacture thereof, pharmaceutical compositions containing them, and their use for treating CNS disorders:wherein A, B, X, Y, R1, R2, R3 and R4 are as defined in the description and claims.